Waldenström's macroglobulinemia surgery: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with | Surgery is not the first-line treatment option for patients with Waldenström macroglobulinemia. [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory Waldenström macroglobulinemia. | ||
==Surgery== | ==Surgery== | ||
[[Stem cell transplant]] is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.<ref name = "sure"> Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
==References== | ==References== | ||
Line 14: | Line 14: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 15:18, 31 October 2018
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia surgery On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Surgery is not the first-line treatment option for patients with Waldenström macroglobulinemia. Stem cell transplant is usually reserved for patients with either relapse or refractory Waldenström macroglobulinemia.
Surgery
Stem cell transplant is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.[1]
References
- ↑ Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015